Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bullboard Posts
Post by jdstoxon Oct 19, 2019 2:15pm
118 Views
Post# 30247510

Two-siders

Two-siders
Beenthere said, "If JD says it's so ... Then it must be"
 
Well, you see, here's the difference.
 
beenthere, digitel and others remain involved with Bioasis. They're here posting and I assume they own shares. But I think they're as scared about losing the argument as they are about losing money.
 
Simply put, they choose to play both sides of the argument, "Bioasis is a failure but I still want to own the shares."
 
It's cowardly and intellectually dishonest, besides being hilarious when the "arguments" are invented tripe and 20/20 hindsight.
 
I've stayed on the side of the angels with only one simple argument that even the bozos believe -  xB3 is an extremely valuable technology that will break through, sooner than later.
 
I think I'm right and I'm not going anywhere.
 
I will remind these two-siders who can't take a stand, who have to make both arguments because of some macho alpha dog BS, of my unequivocal one-sided support for Bioasis and xB3, not for CEOs and directors, but for the shareholders and the xB3 platform.  
 
It's simple. If you think that xB3 will not succeed and have its apparent value expressed then you should sell. It is cowardly to take opposing sides of any argument in the hope that you will be recognized for being right when one or the other side of the argument comes true.
 
jdstox
 
Bullboard Posts